Brief: Gen Ilac Q2 Net Result Turns To Profit Of 77.8 Mln Lira YoY
Aug 14 (Reuters) - GEN İLAÇ VE SAĞLIK ÜRÜNLERİ SANAYİ VE TİCARET GENIL.IS: SAID ON WEDNESDAY, Q2 NET PROFIT OF 77.8 MLN LIRA VERSUS NET LOSS OF 245.1 MLN LIRA YEAR AGO Q2 REVENUE OF 4.29 BLN LIRA VERSUS 4.26 BLN LIRA YEAR AGO Source text for Workspace: nIKA5tHk9 Further company coverage: GENIL.IS (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Gen Ilac ve Saglik Urunleri Sanayi Ticaret
See all newsBrief: Gen Ilac Says It Wins Pharmaceutical Tender In Kazakhstan, Expects $1.19 Million Sales Contribution In 2027
Brief: Gen Ilac Says It Participates In Kazakhstan Drug Procurement Tender Via Med Service Plus Authorized By Kazakhstan Representative Office Of Gen Ilac
Brief: Gen Ilac Says It Signs Supply And Distribution Agreement With Incyte On Oct 9
Brief: Gen Ilac Says It Completes Pharmaceutical Manufacturing Plant Investment In Azerbaijan
Brief: Gen Ilac Says It Is To Start Share Buyback Programme For Max 125 Mln Nominal Shares With Allocated Funds Of 1.5 Bln Lira